Matthew Szot
2022
In 2022, Matthew Szot earned a total compensation of $359.6K as Chief Financial Officer at Cadrenal Therapeutics.
Compensation breakdown
| Bonus | $187,500 |
|---|---|
| Other | $172,105 |
| Total | $359,605 |
Szot received $187.5K in bonus, accounting for 52% of the total pay in 2022.
Szot also received $172.1K in other compensation.
Rankings
In 2022, Matthew Szot's compensation ranked 4,855th out of 5,736 executives tracked by ExecPay. In other words, Szot earned more than 15.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,855 out of 5,736 | 15th |
Division Manufacturing | 2,695 out of 3,125 | 14th |
Major group Chemicals And Allied Products | 1,268 out of 1,416 | 11th |
Industry group Drugs | 1,193 out of 1,317 | 9th |
Industry Pharmaceutical Preparations | 872 out of 963 | 9th |
Source: SEC filing on June 11, 2024.
Szot's colleagues
We found two more compensation records of executives who worked with Matthew Szot at Cadrenal Therapeutics in 2022.